Pharmacoeconomic review report Guselkumab (Tremfya) (Janssen Inc.)
Guselkumab (Tremfya) is a fully human immunoglobulin G1 lambda (IgG1a) monoclonal antibody that binds selectively to the interleukin 23 (IL-23) protein with high specificity and affinity. Levels of IL-23 are elevated in the skin of patients with plaque psoriasis and guselkumab exerts its clinical ef...
| Main Author: | |
|---|---|
| Corporate Author: | |
| Format: | eBook |
| Language: | Inglés |
| Published: |
Ottawa (ON) :
CADTH
2018.
|
| Subjects: | |
| See on Biblioteca Universitat Ramon Llull: | https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009820269606719 |
